Ponatinib circumvents all types of imatinib resistance in chronic myelogenous leukemia cell lines

Published 2013 View Full Article

  1. Home
  2. Publications
  3. Publication Search
  4. Publication Details
Title
Ponatinib circumvents all types of imatinib resistance in chronic myelogenous leukemia cell lines
Authors
Keywords
-
Journal
CELL CYCLE
Volume 12, Issue 11, Pages 1645-1646
Publisher
Informa UK Limited
Online
2013-06-01
DOI
10.4161/cc.24982
References
View 5 related references

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started
Webinars Posters Questions Hubs Funding Journals Articles Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.